Cyclin D3-dependent kinases in lymphoma: redundancy and implications for therapy.
Martin
M
Mistrik
Jiri
J
Bartek
D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D056743:Cyclin D3 / Q000378:metabolism*; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D016193:G1 Phase / Q000187:drug effects; D006801:Humans; D008223:Lymphoma / Q000201:enzymology* / Q000473:pathology / Q000628:therapy*; D008958:Models, Molecular; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D016196:S Phase / Q000187:drug effects
D056743:Cyclin D3; D047428:Protein Kinase Inhibitors; D018844:Cyclin-Dependent Kinases